Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06794775
Title SWE-NEO: Swedish NeoAdjuvant Trial Comparing Monotherapy to Combined Immunotherapy in Resectable Stage III Melanoma (SWE-NEO)
Acronym SWE-NEO
Recruitment Not yet recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Hildur Helgadottir
Indications
Therapies
Age Groups: adult | senior
Covered Countries SWE


No variant requirements are available.